Maryland HB1114 mandates insurance coverage for HIV prevention drugs and outlines pharmacist roles.

Maryland HB1114 requires the Maryland Medical Assistance Program to cover HIV prevention drugs, including preexposure and postexposure prophylaxis. It mandates that pharmacists complete a training program before prescribing these drugs. The bill prohibits insurers and managed care organizations from imposing prior authorization, step therapy, or cost-sharing for these medications. It also requires the State Board of Pharmacy to develop a notification plan and convene a workgroup to consider collaborative practice agreements for pharmacists.

Maryland HB1114 mandates insurance coverage for HIV prevention drugs and outlines pharmacist roles.

Maryland HB1114 requires the Maryland Medical Assistance Program to cover HIV prevention drugs, including preexposure and postexposure prophylaxis. It mandates that pharmacists complete a training program before prescribing these drugs. The bill prohibits insurers and managed care organizations from imposing prior authorization, step therapy, or cost-sharing for these medications. It also requires the State Board of Pharmacy to develop a notification plan and convene a workgroup to consider collaborative practice agreements for pharmacists.